The 18F-fluorodeoxyglucose positron emission tomograhy in predicting residual retroperitoneal tumor after chemotherapy of testis germ cell tumors
-
摘要:
目的 探讨睾丸生殖细胞肿瘤化疗后18F-FDG PET对腹膜后残留病灶的准确性判断。 方法 回顾性分析2014年2月至2016年12月北京大学肿瘤医院泌尿外科16例睾丸生殖肿瘤伴腹膜后淋巴结转移患者的资料，4~6个疗程的博来霉素+顺铂+依托泊苷（BEP）化疗后行腹部CT检查，所有患者的腹膜后肿块直径＞2 cm。18F-FDG PET检查后行腹膜后淋巴结清扫术，并进行术后病理与术前18F-FDG PET结果比较。 结果 16例患者中10例18F-FDG PET结果阳性，其中5例术后病理存在肿瘤残留、5例无肿瘤残留组织；6例18F-FDG PET结果为阴性，2例术后病理肿瘤残留患者均为成熟畸胎瘤、4例无肿瘤组织残留。18F-FDG PET的准确率为56.25%（9/16），灵敏度为71.42%（5/7），特异度为44.44%（4/9），阳性预测率为50.00%（5/10），阴性预测率为66.67%（4/6）。 结论 18F-FDG PET灵敏度较高，但多种因素会影响18F-FDG PET结果的准确性，成熟畸胎瘤易造成18F-FDG PET的假阴性，大量炎性组织易造成18F-FDG PET假阳性，需结合多种检查提高结果准确性。 -
关键词:
- 18F-FDG PET /
- 睾丸生殖细胞肿瘤 /
- 腹膜后淋巴结清扫术
Abstract:Objective To determine the value of 18F-fluorodeoxyglucose positron emission tomography(18F-FDG PET)scans in identifying the residual retroperitoneal tumor after chemotherapy of testis germ cell tumors. Methods Sixteen testis germ cell tumor patients with metastasis of retroperitoneal lymph nodes who were treated in our hospital from February 2014 to December 2016 were selected for the study from February 2014 to December 2016.After 4-6 cycles of chemotherapy, their CT scans showed residual masses with diameters greater than 2 cm.The retroperitoneal lymph nodes were dissected after the 18F-FDG PET exam.The post-surgery pathology results were compared with the results of the 18F-FDG PET exam. Results Residual tumors were found in 5 of 10 patients with 18F-FDG PET positive.Residual tumor was absent in 4 of 6 patients with 18F-FDG PET negative, while residual mature teratoma tumors were found in two patients.The accuracy rate, sensitivity, specificity, positive predictive value(PPV), and negative predictive value(NPV)of the 18F-FDG PET exam were 56.25%(9/16), 71.42%(5/7), 44.44%(4/9), 50.00%(5/10), and 66.67%(4/6), respectively. Conclusion 18F-FDG PET is highly sensitive.However, many factors influence the result of 18F-FDG PET.Mature teratoma leads to a false negative result, whereas massive tissue inflammation leads to a false positive result.Therefore, more clinical examinations should be made. -
表 1 患者一般资料
Table 1. Patients' pre-operative data
表 2 16例睾丸癌患者BEP化疗后临床资料
Table 2. Clinical data of 16 testis cancer patients after BEP chemotherapy
-
[1] Spiess PE, Brown GA, Liu P, et al.Recurrence pattern and proposed surveillance protocol following post chemotherapy retroperitoneal lymph node dissection[J].J Urol, 2007, 177(1):131-138. doi: 10.1016/j.juro.2006.08.092 [2] Eihorn LH.Complicated problems in testicular cancer[J].Semin Oncol, 1988, 15(3 Suppl):9-15. https://www.ncbi.nlm.nih.gov/pubmed/3293217 [3] Utech CI, Young CS, Winter PF.Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry[J].Eur J Nucl Med, 1996, 23(12):1588-1593. doi: 10.1007/BF01249621 [4] Delbeke D, Vitola JV, Sandler MP, et al.Staging recurrent metastatic colorectal carcinoma with PET[J].J Nucl Med, 1997, 38(8):1196-1201. http://jnm.snmjournals.org/content/38/8/1196.short [5] Freudenberg LS, Fisccher M, Antoch G, et al.Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical careinomja of unknown primary[J].Med Princ Pract, 2005, 14(3):155-160. doi: 10.1159/000084632 [6] Schelling M, Avril N, Nährig J, et al.Positron emission tomographyusing [(18) F]-fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer[J].J Clin Oncol, 2000, 18(8):1689-1695. doi: 10.1200/JCO.2000.18.8.1689 [7] Smith IC, Welch AE, Hutcheon AW, et al.Positron emission tomography using [(18) F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy[J].J Clin Oncol, 2000, 18(8):1676-1688. doi: 10.1200/JCO.2000.18.8.1676 [8] Lassen U, Daugaard G, Eigtved A, et al.Whole body FDG-PET in patients with stage Ⅰ non-seminomatous germ cell tumors[J].Eur J Nucl Med Mol Imaging, 2003, 30(3):396-402. doi: 10.1007/s00259-002-1075-z [9] Cremerius U, Wildberger JE, Borchers H, et al.Does positron emission tomography using 18Ffluoro-2-deoxyglucose improve clinical staging of testicular cancer?-results of a study in 50 patients[J].Urology, 1999, 54(5):900-904. doi: 10.1016/S0090-4295(99)00272-1 [10] Bokemeyer C, Kollmannsberger C, Oechsle K, et al.Early prediction of treatment response to high dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18) F] FDG PET[J].Br J Cancer, 2002, 86(4):506-511. doi: 10.1038/sj.bjc.6600122 [11] Spermon JR, De Geus-Oei LF, Kiemeney LA, et al.The role of(18) fluoro-2-dexyglucose positron emission tomographyin initial staging and re-staging after chemotherapy for testicular germ cell tumors[J].BJU Int, 2002, 89(6):549-556. doi: 10.1046/j.1464-410X.2002.02641.x [12] Akbulut Z, Canda AE, Atmaca AF, et al.Is positron emission tomography reliable to predict post-chemotherapy retroperitoneal lymph node involvement in advanced germ cell tumors of the testis[J]?Urol J, 2011, 8(2):120-126. https://www.ncbi.nlm.nih.gov/pubmed/21656470 [13] Siekiera J, Malkowski B, Józwicki W, et al.Can we rely on PET in the follow-up of advanced seminoma patients[J]? Urol Int, 2012, 88(4):405-409. http://www.karger.com/Article/Abstract/337056 -
点击查看大图
表(2)
计量
- 文章访问数: 46
- HTML全文浏览量: 3
- PDF下载量: 1
- 被引次数: 0
下载:
